These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21368431)

  • 21. Hepatic gene therapy using adeno-associated virus vectors.
    Patijn GA; Kay MA
    Semin Liver Dis; 1999; 19(1):61-9. PubMed ID: 10349684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Precise hit: adeno-associated virus in gene targeting.
    Vasileva A; Jessberger R
    Nat Rev Microbiol; 2005 Nov; 3(11):837-47. PubMed ID: 16261169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adeno-associated virus-mediated gene delivery.
    Snyder RO
    J Gene Med; 1999; 1(3):166-75. PubMed ID: 10738565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors.
    Müller OJ; Kaul F; Weitzman MD; Pasqualini R; Arap W; Kleinschmidt JA; Trepel M
    Nat Biotechnol; 2003 Sep; 21(9):1040-6. PubMed ID: 12897791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro packaging of an infectious recombinant adeno-associated virus 2.
    Ding L; Lu S; Munshi NC
    Gene Ther; 1997 Nov; 4(11):1167-72. PubMed ID: 9425439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical gene therapy using recombinant adeno-associated virus vectors.
    Mueller C; Flotte TR
    Gene Ther; 2008 Jun; 15(11):858-63. PubMed ID: 18418415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Production of recombinant adeno-associated virus vectors using a packaging cell line and a hybrid recombinant adenovirus.
    Liu XL; Clark KR; Johnson PR
    Gene Ther; 1999 Feb; 6(2):293-9. PubMed ID: 10435114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential internalization and nuclear uncoating of self-complementary adeno-associated virus pseudotype vectors as determinants of cardiac cell transduction.
    Sipo I; Fechner H; Pinkert S; Suckau L; Wang X; Weger S; Poller W
    Gene Ther; 2007 Sep; 14(18):1319-29. PubMed ID: 17611587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An improved system for packaging recombinant adeno-associated virus vectors capable of in vivo transduction.
    Flotte TR; Barraza-Ortiz X; Solow R; Afione SA; Carter BJ; Guggino WB
    Gene Ther; 1995 Jan; 2(1):29-37. PubMed ID: 7712331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant adeno-associated virus derived vectors (rAAV2) efficiently transduce ovarian and hepatocellular carcinoma cells--implications for cancer gene therapy.
    Małecki M; Swoboda P; Pachecka J
    Acta Pol Pharm; 2009; 66(1):93-9. PubMed ID: 19226976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Construction and identification of recombinant adeno-associated virus vector harboring fusion gene NT4-Apoptin-HA2-TAT].
    Wang JS; Zhang MX; Liu DC; Duan XY; Zhou SN; Zhang GJ; Yang GX; Wang QY
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Aug; 24(8):754-6. PubMed ID: 18687210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficient and long-term intracardiac gene transfer in delta-sarcoglycan-deficiency hamster by adeno-associated virus-2 vectors.
    Li J; Wang D; Qian S; Chen Z; Zhu T; Xiao X
    Gene Ther; 2003 Oct; 10(21):1807-13. PubMed ID: 12960970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of atherosclerosis in apolipoprotein-E-deficient mice following muscle transduction with adeno-associated virus vectors encoding human apolipoprotein-E.
    Harris JD; Schepelmann S; Athanasopoulos T; Graham IR; Stannard AK; Mohri Z; Hill V; Hassall DG; Owen JS; Dickson G
    Gene Ther; 2002 Jan; 9(1):21-9. PubMed ID: 11850719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Transfection of human 293 and CD34+ cells with recombinant green fluorescent protein adeno- associated virus].
    Li LB; Feng R; Zhou SY
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Jan; 25(1):26-9. PubMed ID: 15683991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Oral recombinant adeno-associated virus gene medicine].
    Diao Y; Xu RA
    Yao Xue Xue Bao; 2009 Jul; 44(7):703-9. PubMed ID: 19806906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Manufacturing and characterizing AAV-based vectors for use in clinical studies.
    Wright JF
    Gene Ther; 2008 Jun; 15(11):840-8. PubMed ID: 18418418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adeno-associated virus mediated expression of human erythropoietin in vitro.
    Diao Y; Xu RA; Wang GJ; Zhao XC
    Acta Pharmacol Sin; 2002 Jan; 23(1):55-8. PubMed ID: 11860738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene transfer by adeno-associated virus vectors into the central nervous system.
    Xiao X; Li J; McCown TJ; Samulski RJ
    Exp Neurol; 1997 Mar; 144(1):113-24. PubMed ID: 9126160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene therapy progress and prospects: recombinant adeno-associated virus (rAAV) vectors.
    Flotte TR
    Gene Ther; 2004 May; 11(10):805-10. PubMed ID: 15042119
    [No Abstract]   [Full Text] [Related]  

  • 40. The next step in gene delivery: molecular engineering of adeno-associated virus serotypes.
    Wang J; Faust SM; Rabinowitz JE
    J Mol Cell Cardiol; 2011 May; 50(5):793-802. PubMed ID: 21029739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.